Navigation Links
Genmab Announces Updates on Phase III Cancer Studies
Date:5/29/2008

met medical needs. Using cutting-edge antibody technology, Genmab's world class discovery, development and manufacturing teams have created and developed an extensive pipeline of products for potential treatment of a variety of diseases including cancer and autoimmune disorders. As Genmab advances towards a commercial future, we remain committed to our primary goal of improving the lives of patients who are in urgent need of new treatment options. For more information on Genmab's products and technology, visit http://www.genmab.com.

This press release contains forward looking statements. The words "believe", "expect", "anticipate", "intend" and "plan" and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with product discovery and development, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products obsolete, and other factors. Genmab is not under an obligation to up-date statements regarding the future following the publication of this release; nor to confirm such statements in relation to actual results, unless this is required by law.

Genmab(R); the Y-shaped Genmab logo(R); HuMax(R); HuMax-CD4(R); HuMax-CD20(R); HuMax-EGFr(TM); HuMax
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS
2. Bionomics Achieves US$1 Million Milestone Payment from Genmab
3. DAHANCA Initiates Head and Neck Cancer Study With Genmabs HuMax-EGFr
4. Kiadis Pharma Announces Collaboration With the Julius Maximilians University of Wurzburg, Germany
5. Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial
6. BioElectronics Announces Major Clinical Trials
7. Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting
8. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
9. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
10. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
11. BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  Today the U.S. Food ... Bexsero® for the prevention of serogroup B meningococcal ... and Pfizer,s vaccine Trumenba®, which received FDA approval in ... this devastating disease. "I have heard ...
(Date:1/23/2015)... Jan. 23, 2015  The Partnership to Fight Chronic Disease (PFCD) released ... care leaders and a new study analyzing the impact of increased ... a nationwide coalition working to educate policy makers and the public ... Capitol was focused on how the Iowa ...
(Date:1/23/2015)... Jan. 23, 2015 More than a third of reproductive-aged ... those with private insurance, filled a prescription for an opioid ... in this week,s Morbidity and Mortality Weekly Report (MMWR). ... to treat moderate to severe pain.  They are also found ...
Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
... risk of breast cancer recurrence , , ... taking tamoxifen with certain antidepressants more than doubled the ... medications. The antidepressants inhibit an enzyme, CYP2D6, which helps ... ) , , The study was conducted ...
... of Clinical Oncology Annual MeetingAbstracts: 5033, 3560ORLANDO, Fla., ... Phase I and II trials of BAY 73-4506, ... in multiple tumor types. These data were ... American Society of Clinical Oncology (ASCO)."Bayer is committed ...
Cached Medicine Technology:New Research Shows Antidepressants May Thwart Breast Cancer Treatment 2New Research Shows Antidepressants May Thwart Breast Cancer Treatment 3Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506 2Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506 3
(Date:1/22/2015)... 2015 The U.S. Pharmacopeial Convention is ... of Clinical Pharmacy Services at North Carolina State’s College ... the 2015 Beal Award for Distinguished Volunteer Service—the organization’s ... on the contributions of volunteer experts to direct its ...
(Date:1/22/2015)... 22, 2015 The City of West Hollywood hosted ... to commemorate the 42nd anniversary of the Supreme Court decision Roe ... been 42 years since the Roe vs. Wade decision and the ... present as ever,” said City of West Hollywood Councilmember Abbe Land. ...
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in Glendale, AZ has ... (PPHA). The PPHA's passion for others' well-being and shared ... treated for obstructive sleep apnea (OSA) has propelled them into ... the valley. The most recent plans for an event will ...
(Date:1/22/2015)... Angelweddingdress is a famous wedding dress company offering many trendy ... on Facebook, Twitter, and Pinterest. The fans will have an ... lottery every week. , Moreover, the company has extended its ... Angelweddingdress homepage for more information. , Angelweddingdress is ...
(Date:1/22/2015)... January 22, 2015 The federal court overseeing ... U.S. District Court, Southern District of West Virginia has upheld ... that proceeding’s first bellwether trial. In an Order dated January ... trial after finding that C.R. Bard had not proven a ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4
... Nanotechnology is the use of particles which are very ... pose a health hazard. // The petition was raised ... Administration (FDA) to strengthen its regulation of sunscreens that ... are thought to cause inflammatory and immune responses in ...
... the situation in case of an outbreak of bird flu ... preparation.// They are asked to appoint a bird flu tsar. ... have to look harder at immediate practical measures and implement ... ,He said that their problem is that the decision-making was ...
... outlined programs to ease bureaucratic procedures in the department. // ... by the minister in Launceston this morning to 200 of ... is to reduce the number of approvals needed for day-to-day ... within the bureaucratic process and we're addressing those,’ she said. ...
... has been found that cardiovascular clinical trials published between ... whether they were funded by for-profit //organizations or by ... the May 17 issue of JAMA. ,Surveys ... awareness in the medical community that trials funded by ...
... not yet ascertained the top floors of the Melbourne office ... identify the cause of illnesses.// ,Tests on radiofrequency ... establish any link as yet to the seven cases of ... ,Five of these seven cases were employees who had worked ...
... is associated with the formation of blood clots during long ... is thought to be, reveals a new study. ,The ... people, while sitting in cramped places, that cause a reduction ... the formation of clots. This is perhaps the reason why ...
Cached Medicine News:Health News:Results of Clinical Trials Vary According to Source of Funding 2
This contact glass serves to examine the ora serrata, the pars plana and the extreme peripheral parts of the vitreous body and the ocular fundus....
... anatomical conditions in the area of the front ... the iridocorneal angle can only be ascertained by ... 900, with its swivelling and declinable illumination, is ... expanse of the entire angle of the iris, ...
An antegrade femoral nail....
A distal femoral nail providing high purchase in osteoporotic metaphyseal bone and two distal locking options: one spiral blade plus one locking screw or two locking screws....
Medicine Products: